Rifater

Active Ingredient(s): Isoniazid, INH + Pyrazinamide, PZA + Rifampin
FDA Approved: * May 31, 1994
Pharm Company: * SANOFI AVENTIS US
Category: Tuberculosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Rifater Overview

Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires’ disease.[2] It is almost always used together with other antibiotics, except when given to prevent Haemophilus influenzae type b and meningococcal disease in people who have been exposed to those bacteria.[2] Before treating a person for a long period of time, measurements...

Read more Rifater Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rifampicin

Recent Rifater Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Isoniazid, INH + Pyrazinamide, PZA + Rifampin
  • Tablet: 50mg + 300mg + 120mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rifater: (2 results)

Sorted by National Drug Code
  • 0088-0576 Rifater 120/50/300 (Rifampin / Isoniazid / Pyrazinamide) Oral Tablet by Sanofi-aventis U.S. LLC
  • 49349-013 Rifater 120/50/300 (Rifampin / Isoniazid / Pyrazinamide) Oral Tablet by Remedyrepack Inc.

Drugs with one or more similar ingredients: (11 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA